OPEN PROTOCOLS
Click on the title to be taken to the NCI web page describing the study.

Protocol	Protocol Title
AMC-045	Phase II Trial Of Combined Modality Therapy Plus Cetuximab in HIV-Associated Anal Carcinoma
AMC-046	A Phase II Trial of Cidofovir in HIV-Infected Patients With High-Grade Perianal Dysplasia
AMC-047	Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma
AMC-048	Prospective Phase II Study Of A High Dose, Short Course Regimen (R-CODOX-M/IVAC) Including CNS Penetration And Intensive IT Prophylaxis In HIV-Associated Burkitt’s And Burkitt’s-Like Lymphoma
AMC-051	Pilot Study Of Rapamycin In Patients With HIV-Associated Kaposi's Sarcoma
AMC-052	Single-Arm, Open-Label Trial Of The Safety And Immunogenicity Of A Quadrivalent Human Papillomavirus Vaccine In HIV-1-Infected Men